When Orexo’s website required a review, the company decided to create a new site from scratch—while also changing its service provider for distribution for reports and press releases.
Together with Orexo, Solberg developed a structure that better showcases the company’s vision and commitment, focusing on the R&D activities where the new formulation technology, AmorphOX®, is central. Also, the content was updated, transparency around financial information was improved, and sustainability KPIs were established. Orexo’s successful sustainability efforts run as a common thread throughout the website.
The collaboration with Orexo includes both financial communication and brand development. In designing the website, we based our work on the company’s visual identity, creating continuity and a uniform experience for the visitors.
The MFN service from Modular Finance was chosen as the new distribution service for communication with the capital market,. The investor pages were updated with, shareholder data, stock statistics, and key figure tables—content that is updated automatically.
Our collaboration with Solberg has been smooth and close. Their understanding of our needs and their ability to deliver high-quality solutions has been a great support in our communication efforts. We appreciate their strong commitment and ongoing support
The new website is a modern, cloud-based solution for the new multilingual corporate site, featuring a press release flow and automatic updates of its content. It was created in the modern and cost-effective Umbraco CMS—a tool that offers great opportunities to create engaging pages while being easy to work with to keep the content updated.
PARTICULARLY APPRECIATED FEATURES
- Integration with the press release flow via Modular Finance’s MFN service
- Integration with Modular Finance’s Datablocks service
- Subscription modules (for press releases and news)
- Stock ticker and graphs
- Calendar functions
- Filtering of press releases by regulatory information and reports (MAR)
- Report and presentation archive
About Orexo
Orexo is a Swedish pharmaceutical company with 30 years of experience in developing improved medicines based on proprietary formulation technologies that meet significant medical needs. In the US market, Orexo offers innovative treatment solutions for patients suffering from opioid dependence and related disorders. Solberg and Orexo have collaborated on the company’s communication since 2016, undertaking projects in both corporate branding and financial reporting.
Result
Contact us to know more!
Fredrik Rittberger
Senior Consultant and Digital Advisor
